Dr Susana Banerjee talks to ecancer at the Ovacome Member's Day 2019 about the latest in ovarian cancer treatment.

She discusses the importance of clinical trials in progressing with new treatment options giving an example of the SOLO-1 trial examining the use of olaparib.

Dr Banerjee believes that there is a building momentum in progressing clinical trials in ovarian cancer and in particular in the rarer types of the disease.